Why is Gennex Lab. falling/rising?

As of 15-Sep, Gennex Laboratories Ltd is experiencing a rise in its stock price, currently at 11.80, reflecting an increase of 0.45 or 3.96%. Today's price summary indicates that the stock has outperformed its sector by 4.41% and has gained after two consecutive days of decline. However, despite this positive movement, the stock's performance over the past month shows a decline of 2.64%, and it has underperformed significantly over the year with a return of -51.22%. The company has a low Debt to Equity ratio of 0.05, indicating financial stability, and has shown healthy long-term growth with an operating profit growth rate of 53.70%. Nevertheless, the low Return on Equity (ROE) of 8.68% and flat results in the latest quarter, including a significant portion of non-operating income, raise concerns about management efficiency and profitability. Broader market context reveals that Gennex Laboratories Ltd has outperformed the Sensex in the short term, with a 1-week return of +4.70% compared to the Sensex's +1.24%. However, the stock has underperformed the broader market over the past year, where the BSE500 index saw a decline of only -3.45%. This contrast highlights the challenges faced by Gennex Laboratories Ltd, as it struggles with a substantial year-to-date decline of -27.78% while the market has shown a modest gain of 4.67%. The liquidity of the stock remains adequate for trading, but the falling investor participation, with a significant drop in delivery volume, suggests caution among investors.